当前位置: X-MOL 学术Antivir. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Antiviral Research ( IF 4.5 ) Pub Date : 2019-12-16 , DOI: 10.1016/j.antiviral.2019.104694
Qian Chen 1 , Celia Perales 1 , María Eugenia Soria 2 , Damir García-Cehic 1 , Josep Gregori 3 , Francisco Rodríguez-Frías 4 , María Buti 1 , Javier Crespo 5 , José Luis Calleja 6 , David Tabernero 4 , Marta Vila 7 , Fernando Lázaro 8 , Ariadna Rando-Segura 7 , Leonardo Nieto-Aponte 7 , Meritxell Llorens-Revull 1 , Maria Francesca Cortese 7 , Irati Fernandez-Alonso 2 , José Castellote 9 , Jordi Niubó 10 , Arkaitz Imaz 11 , Xavier Xiol 9 , Lluís Castells 1 , Mar Riveiro-Barciela 1 , Jordi Llaneras 1 , Jordi Navarro 12 , Víctor Vargas-Blasco 1 , Salvador Augustin 1 , Isabel Conde 13 , Ángel Rubín 13 , Martín Prieto 13 , Xavier Torras 14 , Nuria Margall 15 , Xavier Forns 16 , Zoe Mariño 16 , Sabela Lens 16 , Martin Bonacci 17 , Sofía Pérez-Del-Pulgar 16 , Maria Carlota Londoño 16 , María Luisa García-Buey 18 , Paloma Sanz-Cameno 18 , Rosa Morillas 19 , Elisa Martró 20 , Verónica Saludes 20 , Helena Masnou-Ridaura 19 , Javier Salmerón 21 , Rosa Quíles 21 , José Antonio Carrión 22 , Montserrat Forné 23 , Mercè Rosinach 23 , Inmaculada Fernández 24 , Javier García-Samaniego 25 , Antonio Madejón 25 , Pilar Castillo-Grau 26 , Carme López-Núñez 27 , María José Ferri 28 , Rosa Durández 29 , Federico Sáez-Royuela 30 , Moisés Diago 31 , Concepción Gimeno 32 , Rafael Medina 32 , Juan Buenestado 33 , Albert Bernet 34 , Juan Turnes 35 , Matilde Trigo-Daporta 36 , Manuel Hernández-Guerra 37 , Manuel Delgado-Blanco 38 , Angelina Cañizares 39 , Juan Ignacio Arenas 40 , Maria Juana Gomez-Alonso 6 , Manuel Rodríguez 41 , Elisabet Deig 42 , Gemma Olivé 43 , Oscar Del Río 43 , Joaquín Cabezas 5 , Ildefonso Quiñones 44 , Mercè Roget 45 , Silvia Montoliu 46 , Juan García-Costa 47 , Lluís Force 48 , Silvia Blanch 49 , Miguel Miralbés 50 , María José López-de-Goicoechea 51 , Angels García-Flores 52 , María Saumoy 11 , Teresa Casanovas 9 , Carme Baliellas 9 , Pau Gilabert 9 , Albert Martin-Cardona 9 , Rosa Roca 9 , Mercè Barenys 53 , Joana Villaverde 9 , Silvia Salord 9 , Blau Camps 9 , María Silvan di Yacovo 9 , Imma Ocaña 12 , Silvia Sauleda 54 , Marta Bes 54 , Judit Carbonell 2 , Elena Vargas-Accarino 2 , Sofía P Ruzo 2 , Mercedes Guerrero-Murillo 2 , Georg Von Massow 2 , María Isabel Costafreda 55 , Rosa Maria López 7 , Leticia González-Moreno 18 , Yolanda Real 18 , Doroteo Acero-Fernández 27 , Silvia Viroles 27 , Xavier Pamplona 27 , Mireia Cairó 23 , María Dolores Ocete 32 , José Francisco Macías-Sánchez 43 , Angel Estébanez 5 , Joan Carles Quer 46 , Álvaro Mena-de-Cea 38 , Alejandra Otero 38 , Ángeles Castro-Iglesias 38 , Francisco Suárez 38 , Ángeles Vázquez 38 , David Vieito 38 , Soledad López-Calvo 38 , Pilar Vázquez-Rodríguez 38 , Francisco José Martínez-Cerezo 56 , Raúl Rodríguez 47 , Ramiro Macenlle 47 , Alba Cachero 57 , Gasshan Mereish 57 , Carme Mora-Moruny 58 , Silvia Fábregas 58 , Begoña Sacristán 59 , Agustín Albillos 60 , Juan José Sánchez-Ruano 61 , Raquel Baluja-Pino 62 , Javier Fernández-Fernández 62 , Carlos González-Portela 62 , Carmen García-Martin 63 , Gloria Sánchez-Antolín 64 , Raúl Jesús Andrade 65 , Miguel Angel Simón 66 , Juan Manuel Pascasio 67 , Manolo Romero-Gómez 68 , José Antonio Del-Campo 68 , Esteban Domingo 69 , Rafael Esteban 1 , Juan Ignacio Esteban 1 , Josep Quer 1
Affiliation  

A percentage of hepatitis C virus (HCV)-infected patients fail direct acting antiviral (DAA)-based treatment regimens, often because of drug resistance-associated substitutions (RAS). The aim of this study was to characterize the resistance profile of a large cohort of patients failing DAA-based treatments, and investigate the relationship between HCV subtype and failure, as an aid to optimizing management of these patients. A new, standardized HCV-RAS testing protocol based on deep sequencing was designed and applied to 220 previously subtyped samples from patients failing DAA treatment, collected in 39 Spanish hospitals. The majority had received DAA-based interferon (IFN) α-free regimens; 79% had failed sofosbuvir-containing therapy. Genomic regions encoding the nonstructural protein (NS) 3, NS5A, and NS5B (DAA target regions) were analyzed using subtype-specific primers. Viral subtype distribution was as follows: genotype (G) 1, 62.7%; G3a, 21.4%; G4d, 12.3%; G2, 1.8%; and mixed infections 1.8%. Overall, 88.6% of patients carried at least 1 RAS, and 19% carried RAS at frequencies below 20% in the mutant spectrum. There were no differences in RAS selection between treatments with and without ribavirin. Regardless of the treatment received, each HCV subtype showed specific types of RAS. Of note, no RAS were detected in the target proteins of 18.6% of patients failing treatment, and 30.4% of patients had RAS in proteins that were not targets of the inhibitors they received. HCV patients failing DAA therapy showed a high diversity of RAS. Ribavirin use did not influence the type or number of RAS at failure. The subtype-specific pattern of RAS emergence underscores the importance of accurate HCV subtyping. The frequency of "extra-target" RAS suggests the need for RAS screening in all three DAA target regions.

中文翻译:

深度测序揭示了与治疗失败相关的广泛的亚型特异性HCV耐药性突变。

一定比例的丙型肝炎病毒(HCV)感染患者未能通过基于直接作用抗病毒(DAA)的治疗方案,这通常是由于与耐药性相关的替代(RAS)。这项研究的目的是表征未通过DAA治疗的一大批患者的耐药情况,并研究HCV亚型和失败之间的关系,以帮助优化这些患者的治疗。设计了一种基于深度测序的新的,标准化的HCV-RAS测试规程,并将其应用于220例先前在DAA治疗失败的患者中亚型的样品中,这些样品在西班牙的39家医院中收集。大多数接受了无DAA干扰素(IFN)α治疗方案。79%的患者接受含sofosbuvir的治疗失败。编码非结构蛋白(NS)3,NS5A,使用亚型特异性引物分析NS5B和NS5B(DAA靶区域)。病毒亚型分布如下:基因型(G)1,62.7%;G3a,21.4%;G4d,12.3%;G2,1.8%;和混合感染1.8%。总体而言,在突变谱中,有88.6%的患者携带至少1种RAS,而19%的患者携带RAS的频率低于20%。有和没有利巴韦林的治疗之间的RAS选择没有差异。无论接受哪种治疗,每种HCV亚型均显示特定类型的RAS。值得注意的是,在治疗失败的患者中,有18.6%的患者的靶蛋白中未检测到RAS,并且有30.4%的患者的RAS蛋白不是其所接受抑制剂的靶标。未能通过DAA治疗的HCV患者表现出较高的RAS多样性。利巴韦林的使用不会影响失败时RAS的类型或数量。RAS出现的亚型特定模式强调了准确的HCV亚型的重要性。“额外目标” RAS的频率表明在所有三个DAA目标区域都需要进行RAS筛查。
更新日期:2019-12-17
down
wechat
bug